Literature DB >> 26388133

Human IgG Antinuclear Antibodies Induce Pregnancy Loss in Mice by Increasing Immune Complex Deposition in Placental Tissue: In Vivo Study.

Manuela Veglia1, Silvia D'Ippolito1, Riccardo Marana1,2, Fiorella Di Nicuolo1, Roberta Castellani1, Valentina Bruno3, Alessia Fiorelli1, Francesco Ria4, Giuseppe Maulucci5, Marco De Spirito5, Giuseppe Migliara4, Giovanni Scambia1, Nicoletta Di Simone1.   

Abstract

PROBLEM: A threefold higher prevalence of antinuclear antibodies (ANA) has been reported in patients with recurrent pregnancy loss (RPL). Nevertheless, the role of ANA in reproductive failure is still unclear. The aim of this study was to investigate the role of ANA during early pregnancy in vivo. METHOD OF STUDY: We used pregnant mice treated with immunoglobulin G (IgG) obtained from normal healthy subjects (NHS); ANA(+) sera of patients with RPL; and ANA(+) sera from women with uncomplicated pregnancies (HW). Placental immunohistochemical/immunofluorescence staining was performed to detect complement and immune complex deposition. ELISA was performed to evaluate complement levels.
RESULTS: ANA(+) IgG from RPL women significantly increased embryo resorption rate, reduced C3, and increased C3a serum levels compared to NHS IgG or ANA(+) -HW IgG. Increased C3 deposition and increased immune complex staining in placental tissues from mice treated with ANA(+) -RPL IgG fraction compared to NHS- and ANA(+) -HW-IgG-treated mice were found.
CONCLUSION: ANA(+) IgG injection in mice is able to induce fetal resorption and complement activation. The presence on placental tissues of immune complexes and complement fragments suggests the complement activation as a possible mechanism of placental damage.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Antinuclear antibodies; complement activation; recurrent pregnancy loss

Mesh:

Substances:

Year:  2015        PMID: 26388133     DOI: 10.1111/aji.12429

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  5 in total

1.  Risk factors for adverse pregnancy outcomes in women with rheumatoid arthritis and follow-up of their offspring.

Authors:  Liang Luo; Xuerong Li; Rui Yan; Huijuan Zhang; Chun Li
Journal:  Clin Rheumatol       Date:  2022-06-13       Impact factor: 3.650

Review 2.  Correlation Between the Presence of Antinuclear Antibodies and Recurrent Pregnancy Loss: A Mini Review.

Authors:  Ting Liu; Xi Guo; Ying Liao; Yingyu Liu; Yuanfang Zhu; Xiaoyan Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-04       Impact factor: 6.055

Review 3.  Undifferentiated Connective Tissue Disease in Pregnancy: A Topic Yet to be Explored.

Authors:  Caterina Serena; Sara Clemenza; Serena Simeone; Sara Zullino; Serena Ottanelli; Marianna Pina Rambaldi; Silvia Vannuccini; Felice Petraglia; Federico Mecacci
Journal:  Front Pharmacol       Date:  2022-01-20       Impact factor: 5.810

4.  Machine Learning (ML) based-method applied in recurrent pregnancy loss (RPL) patients diagnostic work-up: a potential innovation in common clinical practice.

Authors:  N Rosato; E Piccione; V Bruno; M D'Orazio; C Ticconi; P Abundo; S Riccio; E Martinelli; E Zupi; A Pietropolli
Journal:  Sci Rep       Date:  2020-05-14       Impact factor: 4.996

5.  Association of Complement Factor D and H Polymorphisms with Recurrent Pregnancy Loss.

Authors:  Hee Young Cho; Han Sung Park; Eun Ju Ko; Chang Soo Ryu; Jung Oh Kim; Young Ran Kim; Eun Hee Ahn; Woo Sik Lee; Nam Keun Kim
Journal:  Int J Mol Sci       Date:  2019-12-18       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.